Immunotherapy for small cell lung cancer: mechanisms of resistance

G Hamilton, B Rath - Expert opinion on biological therapy, 2019 - Taylor & Francis
Introduction: Small cell lung cancer (SCLC) is a highly malignant disease with a dismal
prognosis that is currently being tested for theclinical activity of checkpoint inhibitors. SCLC …
被引用次数：65 相关文章

Immunotherapy for small cell lung cancer: mechanisms of resistance.

G Hamilton, B Rath - Expert Opinion on Biological Therapy, 2019 - europepmc.org
Small cell lung cancer (SCLC) is a highly malignant disease with a dismal prognosis that is
currently being tested for theclinical activity of checkpoint inhibitors. SCLC is associated with …

Immunotherapy for small cell lung cancer: mechanisms of resistance

G Hamilton, B Rath - Expert opinion on biological therapy, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Small cell lung cancer (SCLC) is a highly malignant disease with a dismal
prognosis that is currently being tested for theclinical activity of checkpoint inhibitors. SCLC …